RxDoctor Payments Data

Saba Aftab, MD

Otolaryngology · Marlton, NJNPI 1760674287

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 90.3% of the total across 215 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 37 manufacturers, the largest accounting for just 19.8% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,602, 2.5 times the $641 reported in 2019. Among otolaryngology clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$6,187in general payments, 2019–2025

Across 215 payments — averaging $28.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Inspire Medical Systems, Inc.$1K
  • Sanofi$879
  • GSK$471
  • Optinose US, Inc.$445
  • Alk-abello, Inc$365
  • Regeneron Healthcare Solutions, Inc.$278
  • plus $3K from 31 others

What the payments were for

  • Travel & lodging$5489%
  • Food & beverage$5,58490%
  • Education$551%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,187 in reported general payments places this provider in the 95th percentile of 232 otolaryngology providers in New Jersey.

See all otolaryngology providers in New Jersey

Medicare billing

Part B allowed, 2024
$145,051
Medicare patients
447
Services billed
1,839

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ipratropium Bromide124$2,749
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth11$1,205
Montelukast Sodium31$490
Omeprazole15$365
Fluticasone Propionate28$298
Meclizine Hcl12$173
Methylprednisolone19$112
Famotidine14$103
Prednisone28$103
Tramadol Hcl11$36

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Marlton

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →